0000905718-21-001259.txt : 20211001 0000905718-21-001259.hdr.sgml : 20211001 20210930182740 ACCESSION NUMBER: 0000905718-21-001259 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211001 DATE AS OF CHANGE: 20210930 EFFECTIVENESS DATE: 20211001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellular Longevity, Inc. CENTRAL INDEX KEY: 0001799919 IRS NUMBER: 301209602 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-415343 FILM NUMBER: 211296224 BUSINESS ADDRESS: STREET 1: 548 MARKET STREET, SUITE 26099 CITY: SAN FRANCISCO STATE: CA ZIP: 94014 BUSINESS PHONE: 408-757-0450 MAIL ADDRESS: STREET 1: 548 MARKET STREET, SUITE 26099 CITY: SAN FRANCISCO STATE: CA ZIP: 94014 D 1 primary_doc.xml X0708 D LIVE 0001799919 Cellular Longevity, Inc. 548 MARKET STREET, SUITE 26099 SAN FRANCISCO CA CALIFORNIA 94014 408-757-0450 DELAWARE None None Corporation true 2019 Celine-Lea Halioua-Haubold 548 Market Street, Suite 26099 San Francisco CA CALIFORNIA 94104 Executive Officer Director Other Technology Decline to Disclose 06b false 2021-08-31 false true true Series A Preferred Stock false 0 28831521 27697449 1134072 Includes the conversion of certain SAFEs false 42 0 0 0 true Some of the proceeds may be used for general working capital purposes, including the payment of salaries and other fees to those listed in Item 3. false Cellular Longevity, Inc. /s/ Celine-Lea Halioua-Haubold Celine-Lea Halioua-Haubold Chief Executive Officer 2021-09-30